We are in the fourth and final year of a study of the relationship between human immunodeficiency virus (HIV), and types of human papillomavirus (HPV), immunosuppression, and risk of development of high grade anal squamous intraepithelial lesions (HGASIL), the anal cancer precursor lesion most closely related to invasive anal cancer (R01CA55488, Nancy Kiviat PI). Our major findings included: a) development of high grade anal squamous intraepithelial lesions (HGASIL) is associated with HIV seropositivity, with HIV seropositive men with CD4 count below 500/mul at greatest risk; b) among both HIV seropositive and HIV seronegative men, development of HGASIL associated with high levels of HPV types 16/18; (c) development of HGASIL is associated with low risk HPV type HPV in addition to HPV 16/18 among HIV seropositive, but not among seronegative men; and d) HIV seronegative were much more likely to regress from HGASIL to normal than were HIV seropositive men. We now propose a survey of questions focused on further exploring the relationship between HIV and HPV. We will: 1) test the hypothesis that the development of ASIL is associated with the presence and amount of HIV; 2) determine whether there is support of the hypothesis that the effect of anal HIV on anal HPV is (a) the result of local HIV induced immunosuppression (b) direct effect of HIV on HPV; and 3) initiate studies examining the characteristics, pathogenesis and clinical consequences of anal HIV variants: by cross sectional analysis of first visit samples. In summary, we propose a survey of questions that are likely to contribute significantly to our understanding of both general HIV pathogenesis and the development of HPV-related pathology among HIV-seropositive men.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG5-ARRD (01))
Program Officer
Starks, Vaurice
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Washington
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Campbell, Mary S; Gottlieb, Geoffrey S; Hawes, Stephen E et al. (2009) HIV-1 superinfection in the antiretroviral therapy era: are seroconcordant sexual partners at risk? PLoS One 4:e5690
Casper, Corey; Redman, Mary; Huang, Meei-Li et al. (2004) HIV infection and human herpesvirus-8 oral shedding among men who have sex with men. J Acquir Immune Defic Syndr 35:233-8
Brumback, Babette; Greenland, Sander; Redman, Mary et al. (2003) The intensity-score approach to adjusting for confounding. Biometrics 59:274-85
Hagensee, M E; Koutsky, L A; Lee, S K et al. (2000) Detection of cervical antibodies to human papillomavirus type 16 (HPV-16) capsid antigens in relation to detection of HPV-16 DNA and cervical lesions. J Infect Dis 181:1234-9
Lampinen, T M; Critchlow, C W; Kuypers, J M et al. (2000) Association of antiretroviral therapy with detection of HIV-1 RNA and DNA in the anorectal mucosa of homosexual men. AIDS 14:F69-75
Critchlow, C W; Hawes, S E; Kuypers, J M et al. (1998) Effect of HIV infection on the natural history of anal human papillomavirus infection. AIDS 12:1177-84
Xi, L F; Critchlow, C W; Wheeler, C M et al. (1998) Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants. Cancer Res 58:3839-44
Kiviat, N B; Critchlow, C W; Hawes, S E et al. (1998) Determinants of human immunodeficiency virus DNA and RNA shedding in the anal-rectal canal of homosexual men. J Infect Dis 177:571-8
Hagensee, M E; Kiviat, N; Critchlow, C W et al. (1997) Seroprevalence of human papillomavirus types 6 and 16 capsid antibodies in homosexual men. J Infect Dis 176:625-31
Kooperberg, C; Clarkson, D B (1997) Hazard regression with interval-censored data. Biometrics 53:1485-94

Showing the most recent 10 out of 12 publications